Medicare Coverage Decision Memo for Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R)

 Medicare Coverage Decision Memo for Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R)

 

CMS was asked to reconsider Section 220.6 of the National Coverage Determination (NCD) Manual to end the prospective data collection requirements across all oncologic indications of FDG PET except for monitoring response to treatment. Section 220.6 of the NCD Manual established the requirement for prospective data collection for FDG PET used in the diagnosis, staging, restaging and monitoring response to treatment for brain, cervical, ovarian, pancreatic, small cell lung and testicular cancers, as well as for cancer indications not previously specified in Section 220.6 in its entirety.

link